An educational resource of the Ocular Immunology and Uveitis Foundation

Massachusetts Eye Research and Surgery Institution
About Us Patient Information Medical Professionals Services

Low Vision | Our Medical Advisor | Member Guidelines | Ask Dr. Foster | Uveitis Glossary | Pars Planitis Forum | Contact Us

Home Page
    > Glenn's Rheumatology Reading Corner
        > Remicade update: New Drug Warnings
New Topic

<< Prev Topic | Next Topic >>
Author
Comment
Webmaster
Administrator
(4/8/07 7:39 pm)


 Remicade update: New Drug Warnings
The FDA said it had received reports of rare cases of an aggressive and often-fatal lymphoma in adolescents and young adults treated with Remicade. The agency is working with the manufacturer to add the information to the drug's prescribing instructions, an FDA statement said.

The company is aware of six reports of hepatosplenic T-cell lymphoma in Crohn's disease patients who took Remicade for varying lengths of time, said Michael Parks, a spokesman for Johnson & Johnson unit Centocor.

May 19, 2006: 5:17 PM EDT
money.cnn.com/2006/05/19/.../index.htm

<< Prev Topic | Next Topic >>


Topic Control Image Topic Commands
Click to receive email notification of replies Click to receive email notification of replies
Click to stop receiving email notification of replies Click to stop receiving email notification of replies
jump to:

- Home Page - Glenn's Rheumatology Reading Corner - Ocular Immunology and Uveitis Foundation, URL>>www.uveitis.org -

Low Vision Instructions | About Our Medical Advisor | Uveitis  Glossary | Office Directions  |  Contact Us



Powered By ezboard® Ver. 7.32
Copyright ©1999-2007 ezboard, Inc.